Find out all the latest news and information from Collins Street Asset Management including quarterly reports and other recommended readings.
Out-of-favour stocks with proven earnings are tipped to deliver this year says, the co-founders of Collins St Asset Management, Michael
Paradigm Biopharmaceuticals (PAR.ASX) have $108M in cash, no debt and are well advanced in the progression of clinical trials in
While fully aware that very few commentators offering their opinion on the health and financial implications of COVID-19 are actually
After years as a successful investment strategy, something has happened to blue chips over the last 5 years. Despite huge